Literature DB >> 9886987

Peripheral and central actions of orphanin FQ (nociceptin) on murine colon.

M A Osinski1, P Bass, E A Gaumnitz.   

Abstract

Orphanin FQ (OFQ), also known as nociceptin, is a recently isolated endogenous peptide with a structure similar to the endogenous opioid peptides. The present study examines the actions of centrally administered OFQ on in vivo murine gastrointestinal and colonic transit as well as the actions of OFQ on the isolated colon. Intracerebroventricular injections of OFQ dose dependently inhibited colonic propulsive activity. OFQ inhibition of colonic propulsion was unaffected by coadministration of the competitive opioid receptor antagonist naltrexone. A subadditive response was observed when approximately equipotent doses of either morphine sulfate or the delta-agonist DPDPE were coadministered with OFQ. No subadditivity was observed with coadministration of the micro-agonist DAMGO, suggesting a functional interaction between OFQ and delta-opioid central pathways regulating colonic transit. High, but not low, doses of OFQ also inhibited the transit of a nonabsorbable charcoal marker through the stomach and/or small intestine. OFQ potently contracted isolated colon preparations; contractile activity was abolished by TTX or chlorpromazine. Our results suggest that OFQ may be an important peptide ligand acting on a novel inhibitory neural pathway that modulates gastrointestinal transit.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9886987     DOI: 10.1152/ajpgi.1999.276.1.G125

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

Review 1.  Pharmacology of nociceptin and its receptor: a novel therapeutic target.

Authors:  G Calo'; R Guerrini; A Rizzi; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

2.  Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters.

Authors:  J J Chen; Z Li; H Pan; D L Murphy; H Tamir; H Koepsell; M D Gershon
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

3.  Orphanin FQ/nociceptin and [Phe(1)Psi(CH(2)-NH)Gly(2)] nociceptin(1-13)-NH(2) stimulate gastric motor function in anaesthetized rats.

Authors:  Z K Krowicki; D R Kapusta; P J Hornby
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 4.  Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands.

Authors:  Elaine C Gavioli; Girolamo Calo'
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-21       Impact factor: 3.000

5.  The nociceptin/orphanin FQ-NOP receptor antagonist effects on an animal model of sepsis.

Authors:  Dickson Carvalho; Fabricia Petronilho; Francieli Vuolo; Roberta Albino Machado; Larissa Constantino; Remo Guerrini; Girolamo Calo; Elaine Cristina Gavioli; Emílio Luiz Streck; Felipe Dal-Pizzol
Journal:  Intensive Care Med       Date:  2008-10-10       Impact factor: 17.440

6.  Protective roles of alpha-calcitonin and beta-calcitonin gene-related peptide in spontaneous and experimentally induced colitis.

Authors:  Brent J Thompson; Mary K Washington; Usha Kurre; Minati Singh; Elizabeth Y Rula; Ronald B Emeson
Journal:  Dig Dis Sci       Date:  2007-05-26       Impact factor: 3.199

7.  Nociceptin effect on intestinal motility depends on opioid-receptor like-1 receptors and nitric oxide synthase co-localization.

Authors:  Andrei Sibaev; Jakub Fichna; Dieter Saur; Birol Yuece; Jean-Pierre Timmermans; Martin Storr
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

8.  Properties of myenteric neurones and mucosal functions in the distal colon of diet-induced obese mice.

Authors:  François Reichardt; Charlotte Baudry; Lisa Gruber; Gemma Mazzuoli; Raphaël Moriez; Christian Scherling; Patrick Kollmann; Hannelore Daniel; Sigrid Kisling; Dirk Haller; Michel Neunlist; Michael Schemann
Journal:  J Physiol       Date:  2013-08-12       Impact factor: 5.182

9.  In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile.

Authors:  A Kuo; B D Wyse; W Meutermans; M T Smith
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

10.  Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes.

Authors:  Yien-Ming Kuo; Zhishan Li; Yun Jiao; Nathalie Gaborit; Amar K Pani; Bonnie M Orrison; Benoit G Bruneau; Benoit I Giasson; Richard J Smeyne; Michael D Gershon; Robert L Nussbaum
Journal:  Hum Mol Genet       Date:  2010-01-27       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.